{"schema_version":"secwatch.filing_event.v1","accession":"0000937556-25-000079","form_type":"8-K","ticker":"MASI","cik":"0000937556","company_name":"MASIMO CORP","filed_at":"2025-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.889657+00:00","generated_at":"2026-05-22T15:58:31.334932+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Masimo Q1 non-GAAP EPS $1.36 (+56% YoY); core revenue $372M (+10%); FY guidance cut on tariffs","bullets":["GAAP revenue $372M, up 10% YoY; non-GAAP EPS $1.36, up 56% from prior year.","Discontinued ops (Sound United) loss of $218M including $295M impairment; held-for-sale.","FY2025 guidance: non-GAAP revenue $1.5B-$1.53B; non-GAAP EPS $4.80-$5.15, includes tariff impact.","Prior FY guidance (ex-tariffs) was EPS $5.30-$5.60; mitigation plans being developed.","CEO Katie Szyman cites strong core healthcare earnings power and double-digit growth."],"urls":{"canonical":"https://secwatch.observer/filing/0000937556-25-000079","json":"https://secwatch.observer/filing/0000937556-25-000079.json","markdown":"https://secwatch.observer/filing/0000937556-25-000079.md","text":"https://secwatch.observer/filing/0000937556-25-000079.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/937556/000093755625000079/0000937556-25-000079-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/937556/000093755625000079/masi-20250506.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T15:58:31.334932+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}